TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $12,077 | -90.2% | 803 | -68.8% | 0.00% | -83.3% |
Q1 2021 | $123,000 | -16.9% | 2,575 | -53.8% | 0.01% | -40.0% |
Q3 2020 | $148,000 | +41.0% | 5,571 | +4.7% | 0.01% | +42.9% |
Q2 2020 | $105,000 | +400.0% | 5,320 | +150.4% | 0.01% | +250.0% |
Q1 2020 | $21,000 | +320.0% | 2,125 | +241.6% | 0.00% | – |
Q2 2019 | $5,000 | +66.7% | 622 | +97.5% | 0.00% | – |
Q2 2017 | $3,000 | -25.0% | 315 | 0.0% | 0.00% | – |
Q1 2017 | $4,000 | -75.0% | 315 | -90.7% | 0.00% | -100.0% |
Q4 2016 | $16,000 | – | 3,386 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |